BLAINTRAVENOUSSOLUTION
Approved
May 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
Octagam Immune Globulin (Human) (immune globulin) by Octapharma. Approved for primary immunodeficiency diseases, immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy and 1 more indications. First approved in 2004.
Drug data last refreshed 20h ago
Mechanism of Action
Pharmacologic Class:
Antigen Neutralization
Worked on Octagam Immune Globulin (Human) at Octapharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.